Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit worldwide.com.
5 Ways to Adapt Your Neurodegenerative Disease Trial
When COVID-19 exploded around the world, in-progress neurodegenerative disease trials – as well as studies preparing to launch – were faced with a sudden and unexpected challenge: how to adapt their approach with the least disruption possible.
If your study is struggling to reinvent its tactics in the face of COVID-19, read this eBook to find out how to overcome challenges in:
- Safety assessments
- Staff training
- Budget control
- Patient risk management
- and more
READ THE E-BOOK